Phocas Financial Corp. Agios Pharmaceuticals, Inc. Transaction History

Phocas Financial Corp.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$29.58 - $49.78 $1.81 Million - $3.04 Million	-61,076 Closed	0 $0
Q3 2021 Nov 16, 2021	BUY	$41.92 - $58.18 $1.3 Million - $1.8 Million	31,018 Added 103.19%	61,076 $2.82 Million
Q2 2021 Aug 16, 2021	BUY	$52.06 - $61.27 $1.56 Million - $1.84 Million	30,058 New	30,058 $1.66 Million

227

56.2M

275K

251K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $2.53B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Phocas Financial Corp., based on Form 13F filings with the SEC.

Stay updated on Phocas Financial Corp. with notifications on news.